LGD-2226
guinea pig2 sources
LGD-2226 is the ancestor that got shelved. Ligand Pharmaceuticals tested it in rats, saw solid bone and muscle data, and moved on. No human trial was ever run, no human dose was ever established. If the family name caught your eye, ligandrol reached human trials and ostarine is the milder entry point. LGD-2226 is a footnote.
What it is
The first SARM out of Ligand Pharmaceuticals’ pipeline, before the company moved on to ligandrol and LGD-3303. The preclinical story is genuinely interesting: bone, muscle, prostate-sparing selectivity, and even male sexual-behavior assays in rats. The company moved on, and the published record does not say why. When you hear “LGD” in the gym, nobody means this one.
What the research shows
Solid animal work, zero human data. The published record is entirely preclinical:
Realistic protocols
No human dose has ever been tested. You will not find a real community protocol either, because almost nobody runs LGD-2226. If you have sourced something labeled LGD-2226, start by questioning whether it actually is: the odds of a grey-market capsule containing this specific shelved precursor, rather than mislabeled ligandrol or something else entirely, are not great. A third-party COA is the minimum. If the COA checks out and you still want to run it, go low, go short, pull bloodwork before and after, and plan for PCT because suppression is the class rule. Every SARM is WADA-prohibited in tested sport.
Side effects
No human side-effect data. The SARM class profile and common sense apply:
Where to buy
No live listings from tracked vendors right now.